Financhill
Back

Corcept Therapeutics Stock Predictions

Corcept Therapeutics Stock Forecast

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 32.3% based on the past 21 years of stock performance.
  • Corcept Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
  • Is Corcept Therapeutics Stock Undervalued?
    The current Corcept Therapeutics [CORT] share price is $71.18. The Score for CORT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 32.3% based on the past 21 years of stock performance.

Corcept Therapeutics Stock Rating

Buy
53
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics overpriced?

  • Corcept Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%

Corcept Therapeutics Stock Price History

Is CORT stock going to rise?

  • The current trend is moderately bearish and CORT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com

52-Week Data

52-Week High:
117.33
52-Week Low:
28.04

Prediction Charts

Market Cap:
7.5B
Price in USD:
71.18
Volume:
1.6M
Beta:
0.78

Technical Analysis

SMA50:
72.03
SMA100:
67.66
SMA200:
57.97
52-Wk Change:
118.08%

Stock Predictions

  • Is Corcept Therapeutics stock public?
    Yes, Corcept Therapeutics is a publicly traded company.
  • What is the Corcept Therapeutics stock quote today?
    The Corcept Therapeutics stock price is 71.18 USD today.
  • How to buy Corcept Therapeutics stock online?
    You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-23 74.70 78.69 79.68 74.55
May-27 80.45 76.81 80.65 76.17
May-28 76.40 77.65 78.25 76.40
May-29 78.49 77.64 78.49 76.51
May-30 77.64 77.56 78.70 75.12
Jun-2 77.56 71.68 86.20 70.00
Jun-3 71.10 69.51 72.02 66.50
Jun-4 69.93 69.98 70.69 68.75
Jun-5 69.46 69.01 70.24 67.95
Jun-6 69.65 69.60 70.72 68.76
Jun-9 70.83 70.57 71.23 69.35
Jun-10 70.61 72.27 74.07 70.45
Jun-11 72.29 71.24 73.88 71.16
Jun-12 71.07 71.18 72.01 69.73

Corcept Therapeutics Earnings

Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics Forecast Revenue Growth

Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.

* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.